查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1832504

铸造和夹板市场（按产品类型、材料、最终用户和应用）—2025-2032 年全球预测

Casting & Splinting Market by Product Type, Material, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，石膏和夹板市场将成长 48 亿美元，复合年增长率为 8.04%。

主要市场统计数据
基准年2024年 25.8亿美元
预计2025年 27.9亿美元
预测年份：2032年 48亿美元
复合年增长率（%） 8.04%

为临床、操作和供应链动态提供简洁而权威的框架，塑造石膏和夹板固定，实现基于证据的决策

石膏固定和夹板固定仍然是整形外科、创伤和復健医学领域的基本治疗方法。这些方式与临床结果、器械设计和供应链动态息息相关，并且随着新材料、製造方法和护理模式改变临床医生的偏好和患者的期望而不断发展。医疗保健专业人员寻求在固定效果与重量、舒适度、渗透性和易用性之间取得平衡的解决方案，而医疗保健系统则寻求能够减少手术时间和后续併发症的器械。

随着采购、报销和营业利润压力的不断增加，製造商和临床领导者必须在产品创新、培训和库存策略上保持一致。热塑性塑胶和复合铸造系统的技术进步正在引入替代应用技术和新的灭菌考虑因素，促使人们重新评估临床通讯协定。同时，门诊手术中心和居家医疗提供者正在扩大其在骨折管理和术后固定方面的作用，需要针对分散环境进行优化的产品。

本介绍为更深入分析转型转变、政策影响、细分细微差别、区域动态、竞争格局以及为领导者提供实用建议奠定了基础，领导者必须果断采取行动，在不断变化的环境中保持临床相关性和营运弹性。

影响临床实务、供应链以及石膏和夹板固定技术应用的变革

多种力量共同推动着石膏和夹板固定领域的变革。临床上，人们逐渐转向能够更快应用、改善患者舒适度和增强影像相容性的解决方案。这一趋势推动了人们对合成和热塑性树脂产品的兴趣，这些产品与传统石膏相比，具有更优异的渗透性和更轻的重量。同时，临床医生越来越多地选择能够在临床适当时进行早期活动的固定策略，这影响着产品选择和急性后期护理路径。

从製造角度来看，材料科学的加速创新推动了更高性能的热塑性塑胶和树脂系统的发展，从而实现了更轻、更耐用的结构和新型预製夹板设计。积层製造和数位化试戴工作流程正开始影响客製化矫正器具和夹板解决方案，缩短了前置作业时间，并改善了患者的贴合度。这些进步挑战了传统的供应模式，需要设计工程师、临床教育工作者和采购团队之间更紧密的整合。

在系统方面，医疗保健服务正变得越来越分散，门诊手术中心和居家照护机构承担着越来越多的骨折护理和术后固定任务，因此需要能够简化培训和库存管理的产品。监管部门对安全性、无菌性和可追溯性的重视程度日益加深，迫使製造商加强品质系统和标籤检视清晰度。总而言之，这些变化需要产品开发商、医院系统和经销商做出策略性回应，以确保与新的临床工作流程和经济压力保持一致。

2025年美国关税对铸件采购、生产成本和供应弹性的累积影响

近期针对2025年的关税措施对铸造和夹板价值链产生了多方面的影响。某些聚合物零件和成品医疗设备的进口关税增加了一些製造商和经销商的到岸成本，促使他们迅速审查筹资策略。对于依赖海外热塑性塑胶、玻璃纤维织物和特殊黏合剂供应商的公司来说，其影响既包括营运方面，也包括财务方面。采购团队审查了供应商合同，整合了订单以实现规模化，并考虑了替代运费和海关优化措施，以最大程度地减少中断。

关税也影响了投资决策。一些製造商加快了本地化生产计划，并对国内树脂和织物供应商进行认证，以减轻跨境关税的影响并提高前置作业时间的可靠性。这种向近岸外包的转变影响了生产力计画流程和品质系统以满足当地监管要求。同时，规模较小的供应商面临重新谈判条款并将更高成本转嫁给下游的压力，从而影响了经销商的库存策略和临床采购决策。

临床医生和医院采购负责人对此的回应是强调产品标准化和锁定价格或提供对冲机制的双边协议。付款人和医疗系统关注的是能够缩短住院时间和减少併发症的医疗设备，而不是降低单价，并仔细审查了其对总成本的影响。最终，关税强化了供应链透明度、材料替代评估和情境规划的必要性，以便在不断变化的贸易政策环境中维持服务水准和临床结果。

细分洞察，揭示跨产品类型、材料、最终用户和应用的机会途径

产品类型的差异会影响采用动态和开发优先级：玻璃纤维铸件在强度和重量之间取得平衡；石膏铸件在低成本和可塑性至关重要的情况下仍然适用；夹板（包括动态和静态夹板）越来越多地用于有针对性的固定和康復；合成铸件可提供快速固定，并为特定临床场景提供防水替代品；热塑性铸件提供舒适度。由于每个产品类型都与特定的临床工作流程和培训需求相符，因此产品组合经理必须将开发平臺与最快采用的服务线保持一致。

材料选择决定了製造过程和临床表现。热塑性塑胶分为高温和低温两种类型，可进行定製成型和重复使用。高温热塑性塑胶的特性使其能够支援耐用、半永久性的矫正器具，而低温热塑性塑胶则易于在诊所内成型，从而影响库存和临床医生培训方面的决策。

终端用户细分揭示了不同的采购行为和用例。门诊手术中心优先考虑速度和可预测的设备成本，以管理高吞吐量手术。家庭医疗保健提供者重视轻量级、患者友善的解决方案，以方便居家照护并减轻看护者的负担。公立和私立医院都在临床疗效与感染控制和供应链弹性之间取得平衡。整形外科诊所专注于支援门诊復健通讯协定的专用夹板选项。认识到这些差异有助于制定销售策略、培训计划和产品配置选择。

应用细分有助于明确临床需求驱动因素：矫正模型需要符合解剖学要求并能延长佩戴时间的材料和设计；骨折需要针对下肢和上肢采用不同的固定策略；术后固定则强调舒适性、伤口可及性和影像相容性。了解每种应用的细微差别，製造商和供应商可以优先考虑产品属性，例如重量、透气性、可调节性和放射不渗透性，从而最大限度地提高临床适用性和手术应用率。

区域动态和策略要务正在影响跨地区的招募和供应链选择

区域差异对产品偏好、监管途径和分销模式有显着影响。美洲地区环境复杂，三级医院系统和门诊医疗机构的临床实务模式各异，采购决策往往着重于服务整合、品质保证以及与经销商的合约关係。该地区对合成和热塑性绷带产品的兴趣日益浓厚，这些产品支持快速週转和门诊病人管理，同时又能在资源受限的环境下保留传统OK绷的使用。

欧洲、中东和非洲：欧洲、中东和非洲地区管理体制和报销制度错综复杂，影响医疗器材普及和临床训练的投资。一些地区鼓励透过集中采购简化库存管理的标准化解决方案，而其他地区则强调临床医生的自主判断和客製化的矫正器具服务。该地区的经济多样性既促进了创新机会，也带来了负担能力压力，要求製造商相应地调整其商业化策略和监管支援。

受人口结构变化、都市化以及外科和復健护理投资差异的影响，亚太地区的医疗技术采用轨迹呈现多样性。新兴市场的快速发展推动了对简化医疗服务流程并长期降低成本的技术的需求，而现有系统则强调循证选择以及与电子健康记录健康记录的整合。在全部区域，不断变化的贸易政策和物流限制使得供应链弹性和本地化策略成为核心规划重点，推动了针对特定地区的製造和分销决策，以降低风险并保障产品供应。

影响产品系列、伙伴关係和市场发展的主要竞争对手和公司发展

主要企业正在追求产品创新、临床教育和分销优化的结合。新的材料配方和预製夹板设计体现了对以用户为中心的成果的关注，例如更轻的结构、更好的透气性以及与显像模式的兼容性。器械製造商和临床网路之间的策略伙伴关係正在加速发展，这得益于对培训计画的关注，这些计画旨在缩短临床医生的学习曲线，并节省实际应用时间。

合作也延伸至供应链伙伴关係和製造外包关係，以确保原材料和灵活的生产能力。积极实现供应商多元化并投资本地製造能力的公司降低了贸易政策波动带来的影响，并提升了服务水准。同时，增强产品选择、适配支援和远端医疗整合数位化工具的公司，为门诊和居家医疗环境创造了差异化的价值提案。这些整合的服务加强了与经销商的关係，并为临床医生提供了决策支援资源，从而缩短了采购週期。

竞争定位日益体现出商品化产品与高利润专业产品之间的平衡。拥有强大临床证据、丰富培训和快速回应技术支援的机构，更有可能在医院系统和门诊病人网路中获得优先供应商的地位。由于报销模式强调价值和疗效，能够证明其设备有助于降低併发症率、减少再入院率并缩短康復时间的公司，很可能在合约谈判中保持明显优势。

行业领导者可以实施的实用且具有高影响力的建议，以增强弹性并加速采用

优先考虑模组化产品系列，使临床医生能够根据其特定的临床路径选择合适的材料和应用方案，从而加快采购审批核准并简化库存管理。投资以临床医生为中心的教育项目，并强调应用效率、患者舒适度和基于结果的用例，以缩短采用週期并降低应用品质的差异性。加强品质文件编制并简化监管提交流程，以简化进入不同地理市场的流程，并加快升级材料的上市时间。

我们将制定供应链策略，包括双重采购、近岸外包可行性研究以及减轻关税影响的合约条款。这些措施将降低贸易政策变革和物流中断带来的脆弱性。同时，我们将建立商业模式，使定价与临床价值而非仅仅与单位成本挂钩，并展示医疗设备的选择如何能够减少整体护理次数、併发症和后续干预。最后，我们将扩展数位化赋能工具，例如适配指南、远端医疗支援和应用后监测，以提高病患满意度，并帮助产生长期证据，从而加强报销谈判。

采用的调查方法确保资料完整性、临床相关性和策略适用性

本次分析整合了主要和次要讯息，以提供全面的、以从业者为中心的评估。主要资讯包括对急诊、门诊和居家照护环境中的临床医生进行结构化访谈，以了解实际应用偏好、采购决定因素和培训差距。次要研究结合了技术文献和材料性能的监管指南，以检验临床声明并提供产品属性的比较评估。

我们运用三角测量法，将相关人员的观点与可观察的供应链指标（例如供应商多元化趋势、区域製造业公告以及影响贸易的公共变化）进行整合。专家检验会议确认，材料替代、医疗服务分散化以及关税主导的近岸外包等新兴主题对其他解释具有稳健性。研究结果为正在考虑投资、产品开发和采购变革的领导者提供了可操作的实务经验和实用框架。

结论整合临床、商业性和政策讯号，为相关人员制定策略重点

铸造和夹板领域正处于曲折点，材料科学、临床工作流程的转变以及贸易政策的发展正在共同再形成策略选择。临床医生和采购领导者必须在传统技术与能够带来更好病患体验和营运效率的创新之间做出权衡，同时应对日益复杂的供应环境。整合临床医生教育、实现供应链多元化并为医疗保健系统提供显着价值的公司将最有可能影响采购决策并保持成长。

展望未来，相关人员应优先考虑证据生成、灵活的製造策略以及以客户为中心的商业化，以满足医院、门诊中心、居家医疗提供者和专科诊所的需求。透过使产品开发与最终用户工作流程和当地物流实际情况保持一致，企业可​​以降低风险、加快采用速度，并确保铸造和夹板方面的创新转化为有意义的临床和营运效益。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 整合 3D 列印和扫描技术，为整形外科患者製作个人化铸模
  • 开发环保可生物降解铸造材料以减少医疗废弃物
  • 穿戴式感测器技术整合到整形外科模型中，用于即时监测
  • 扩大远端医疗，实现远距石膏调整和病患追踪服务
  • 夹板涂有抗菌防潮涂层，以防止二次感染。
  • 引进人工智慧设计软体，优化夹板结构，提升病患舒适度
  • 不断增长的客製化儿科铸模解决方案，满足婴幼儿解剖需求
  • 运动伤害管理和快速动员对柔性热塑性夹板的需求不断增加

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 石膏和夹板市场（依产品类型）

  • 玻璃纤维铸件
  • 石膏模型
  • 夹板
    • 动态夹板固定
    • 静态场景已修復
  • 合成铸件
  • 热塑性铸件

9. 石膏和夹板市场（按材料）

  • 玻璃纤维
  • 几种类型的石膏
  • 热塑性塑料
    • 高温热塑性塑料
    • 低温热塑性塑料

第 10 章。铸造和夹板市场（按最终用户）

  • 门诊手术中心
  • 家庭医疗保健
  • 医院
    • 私立医院
    • 公立医院
  • 整形外科诊所

第 11 章 石膏和夹板市场（按应用）

  • 矫正石膏固定
  • 断裂
    • 下肢骨折
    • 上肢骨折
  • 术后固定

第 12 章。按地区分類的石膏和夹板市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 铸造和夹板市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国铸造及夹板市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • 3M Company
    • Johnson & Johnson
    • BSN Medical GmbH
    • Smith & Nephew plc
    • Ossur hf.
    • Zimmer Biomet Holdings, Inc.
    • Medline Industries, LP
    • Cardinal Health, Inc.
    • McKesson Corporation
    • Paul Hartmann AG
Product Code: MRR-433AB1DC28B4

The Casting & Splinting Market is projected to grow by USD 4.80 billion at a CAGR of 8.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.58 billion
Estimated Year [2025] USD 2.79 billion
Forecast Year [2032] USD 4.80 billion
CAGR (%) 8.04%

A concise, authoritative framing of clinical, operational, and supply-chain dynamics shaping casting and splinting for evidence-driven decision-making

Casting and splinting remain foundational interventions across orthopedics, trauma care, and rehabilitative medicine. These modalities intersect clinical outcomes, device design, and supply-chain dynamics, and they continue to evolve as new materials, fabrication methods, and care-delivery models alter clinician preferences and patient expectations. Practitioners demand solutions that balance immobilization efficacy with weight, comfort, radiolucency, and ease of application, while health systems seek devices that reduce procedure time and downstream complications.

As pressure mounts on procurement, reimbursement, and operating margins, manufacturers and clinical leaders must coordinate on product innovation, training, and inventory strategies. Technological advances in thermoplastics and synthetic casting systems have introduced alternative application techniques and new sterilization considerations, prompting a reassessment of clinical protocols. Concurrently, ambulatory surgical centers and home healthcare providers are expanding their role in fracture management and postoperative immobilization, necessitating products optimized for decentralized settings.

This introduction sets the stage for a deeper analysis of transformative shifts, policy impacts, segmentation nuances, regional dynamics, competitive activity, and practical recommendations for leaders who must act decisively to maintain clinical relevance and operational resilience in a changing environment.

Transformative Shifts Reshaping Clinical Practice, Supply Chains, and Technology Adoption in Casting and Splinting

The casting and splinting landscape is experiencing several converging forces that drive transformation. Clinically, there is a steady migration toward solutions that enable faster application, improved patient comfort, and enhanced imaging compatibility. This trend has increased interest in synthetic and thermoplastic options that offer superior radiolucency and weight reduction compared with traditional plaster. At the same time, clinicians are more selective about immobilization strategies that permit early mobility when clinically appropriate, which affects product selection and post-acute care pathways.

From a manufacturing perspective, materials science innovation has accelerated, with higher-performance thermoplastics and resin systems enabling lighter, more durable constructs and new prefabricated splint designs. Additive manufacturing and digital fitting workflows are beginning to influence custom orthoses and splinting solutions, offering shorter lead times and improved patient fit. These advances challenge legacy supply models and necessitate closer integration between design engineers, clinical educators, and procurement teams.

On the systems side, healthcare delivery is decentralizing; ambulatory surgical centers and home-based care providers are handling a larger share of fracture care and postoperative immobilization, requiring products that simplify training and inventory management. Regulatory emphasis on safety, sterilization, and traceability has intensified, prompting manufacturers to strengthen quality systems and labeling clarity. Taken together, these shifts demand a strategic response from product developers, hospital systems, and distributors to ensure alignment with new clinical workflows and economic pressures.

Cumulative Effects of 2025 United States Tariff Measures on Sourcing, Production Costs, and Supply Resilience in Casting and Splinting

Recent tariff actions in 2025 have had a multifaceted effect on the casting and splinting value chain. Import levies on select polymer components and finished medical devices have raised landed costs for some manufacturers and distributors, prompting rapid reassessment of sourcing strategies. For organizations reliant on overseas suppliers of thermoplastic resins, fiberglass fabrics, and specialized adhesives, the impact has been both operational and financial: procurement teams have revisited supplier contracts, consolidated orders to achieve scale, and explored alternative freight and customs optimization tactics to minimize disruption.

The tariffs have also catalyzed investment decisions. Some manufacturers accelerated plans to localize production or qualify domestic resin and fabric suppliers to reduce exposure to cross-border duties and to improve lead-time reliability. This shift toward nearshoring has implications for capacity planning, capital allocation, and workforce development, as production processes and quality systems are adapted to local regulatory expectations. At the same time, smaller suppliers faced pressure to renegotiate terms or pass cost increases downstream, influencing distributor inventory strategies and clinical purchasing decisions.

Clinicians and hospital procurement leaders responded by emphasizing product standardization and bilateral contracts that lock pricing or provide hedging mechanisms. Payers and health systems scrutinized total cost of care implications, focusing on devices that support reduced length of stay and fewer complications rather than strictly low unit price. Ultimately, the tariffs reinforced the need for supply-chain transparency, material substitution assessments, and scenario planning to preserve service levels and clinical outcomes in an environment of shifting trade policy.

Segmentation Insights That Illuminate Opportunity Paths Across Product Types, Materials, End Users, and Applications

Differentiation across product type influences adoption dynamics and development priorities. Fiberglass casts offer a balance of strength and weight, plaster casts remain relevant where low cost and malleability are paramount, splints-comprising dynamic splints and static splints-are increasingly used for targeted immobilization and rehabilitation, synthetic casts provide rapid-setting, water-resistant alternatives for select clinical scenarios, and thermoplastic casts deliver customizable profiles and improved comfort. Each product category aligns with specific clinical workflows and training needs, so portfolio managers must align development pipelines with the service lines that will adopt them most rapidly.

Material choice shapes manufacturing processes and clinical performance. Fiberglass materials are prized for their tensile strength and radiolucency, plaster of Paris continues to be used where conformability and cost are deciding factors, and thermoplastics-with subdivisions into high temperature and low temperature thermoplastics-enable custom-molding and reusability considerations. The properties of high temperature thermoplastics support durable, semi-permanent orthoses, while low temperature thermoplastics offer convenience for in-clinic molding, influencing decisions about inventory and clinician training.

End-user segmentation reveals divergent procurement behaviors and use cases. Ambulatory surgical centers prioritize speed and predictable device costs as they manage high-throughput procedures. Home healthcare providers emphasize lightweight, patient-friendly solutions that facilitate in-home care and reduce caregiver burden. Hospitals, which include private and public institutions, balance clinical efficacy with infection control and supply-chain resilience. Orthopedic clinics concentrate on specialized splinting options that support outpatient rehabilitation protocols. Recognizing these differences informs sales approaches, training programs, and product configuration choices.

Application-focused segmentation clarifies clinical demand drivers. Corrective casting requires materials and designs that support anatomical conformity and prolonged wear, fractures demand variable immobilization strategies depending on lower limb fractures or upper limb fractures, and postoperative immobilization stresses comfort, wound access, and compatibility with imaging. Understanding the nuances of each application enables manufacturers and providers to prioritize product attributes such as weight, breathability, adjustability, and radiolucency to maximize clinical fit and operational adoption.

Regional Dynamics and Strategic Imperatives Shaping Adoption and Supply-Chain Choices Across Geographies

Regional differences materially influence product preference, regulatory pathways, and distribution models. The Americas present a heterogeneous environment where clinical practice patterns vary between tertiary hospital systems and ambulatory providers; procurement decisions often emphasize service integration, quality assurance, and contractual relationships with distributors. This region shows rising interest in synthetic and thermoplastic options that support rapid turnover and outpatient management, while also maintaining legacy plaster use in resource-constrained settings.

Europe, Middle East & Africa exhibit a complex mosaic of regulatory regimes and reimbursement structures that affect device uptake and clinical training investments. In some jurisdictions, centralized procurement encourages standardized solutions that simplify inventory management, whereas other jurisdictions place greater emphasis on clinician discretion and bespoke orthotic services. Economic diversity within the region drives both innovation opportunities and affordability pressures, so manufacturers must tailor commercialization strategies and regulatory support accordingly.

Asia-Pacific demonstrates varied adoption trajectories driven by demographic shifts, urbanization, and differential investment in surgical and rehabilitative care. Rapidly developing healthcare markets are primed for technologies that streamline care delivery and lower long-term costs, while established systems emphasize evidence-based selection and integration with electronic health records. Across these regions, supply-chain resilience and localization strategies have become central planning priorities due to trade policy shifts and logistics constraints, prompting region-specific manufacturing and distribution decisions to mitigate risk and support steady product availability.

Key Competitive and Corporate Developments Influencing Product Portfolios, Partnerships, and Market Positioning

Leading companies in casting and splinting are pursuing a combination of product innovation, clinical education, and distribution optimization. New material formulations and prefabricated splint designs reflect an emphasis on user-centered outcomes-lighter constructs, improved breathability, and compatibility with imaging modalities. Strategic partnerships between device firms and clinical networks have accelerated by focusing on training programs that shorten clinician learning curves and demonstrate time-savings in application.

Collaboration extends to supply-chain partnerships and contract manufacturing relationships that secure raw materials and flexible capacity. Firms that proactively diversified their supplier base or invested in regional manufacturing capacity reduced exposure to trade policy volatility and improved service levels. Meanwhile, companies enhancing digital tools for product selection, fitting support, and telehealth integration created differentiated value propositions for ambulatory and home-care settings. These integrated offerings strengthen distributor relationships and provide clinicians with decision-support resources that shorten procurement cycles.

Competitive positioning increasingly reflects a balance between commoditized offerings and higher-margin specialty products. Organizations that maintain strong clinical evidence, robust training, and responsive technical support tend to secure preferred-provider status within hospital systems and outpatient networks. As reimbursement models emphasize value and outcomes, companies that can demonstrate device contributions to lower complication rates, reduced readmissions, or shorter recovery timelines will maintain a distinct advantage in contracting conversations.

Practical, High-Impact Recommendations That Industry Leaders Can Deploy to Strengthen Resilience and Accelerate Adoption

Prioritize modular product families that allow clinicians to choose materials and application profiles suited to specific clinical pathways, enabling faster procurement approvals and streamlined inventory management. Invest in clinician-focused education programs that emphasize application efficiency, patient comfort, and outcomes-based use cases to shorten adoption cycles and reduce variability in application quality. Strengthening quality documentation and simplifying regulatory submissions will ease entry into diverse regional markets and reduce time-to-market for upgraded materials.

Develop supply-chain playbooks that include dual sourcing, nearshoring feasibility studies, and contract terms that mitigate tariff exposure. These measures reduce vulnerability to trade-policy shifts and logistics disruptions. Simultaneously, build commercial models that align pricing with clinical value rather than unit cost alone, demonstrating how device selection can reduce total care episodes, complications, or follow-up interventions. Finally, expand digital enablement tools-fitting guides, telehealth support, and post-application monitoring-to improve patient satisfaction and support longitudinal evidence generation that bolsters reimbursement conversations.

Research Methodology Employed to Ensure Data Integrity, Clinical Relevance, and Strategic Applicability

This analysis synthesizes primary and secondary inputs to produce a rounded, practitioner-focused assessment. Primary inputs included structured interviews with clinicians across acute, ambulatory, and home-care settings to capture real-world application preferences, procurement decision drivers, and training gaps. Secondary research incorporated technical literature on materials performance and regulatory guidance to validate clinical claims and to inform comparative assessments of product attributes.

Triangulation methods were applied to reconcile stakeholder perspectives with observable supply-chain indicators, such as supplier diversification trends, regional manufacturing announcements, and public policy changes affecting trade. Expert validation sessions ensured that emerging themes-material substitution, decentralization of care, and tariff-driven nearshoring-were robust against alternate interpretations. The resulting synthesis emphasizes actionable takeaways and practical frameworks for leaders considering investment, product development, or procurement changes.

Conclusion Drawing Together Clinical, Commercial, and Policy Signals to Inform Strategic Priorities for Casting and Splinting Stakeholders

The casting and splinting domain is at an inflection point where material science, clinical workflow changes, and trade-policy developments collectively reshape strategic choices. Clinicians and procurement leaders must weigh traditional techniques against innovations that promise better patient experience and operational efficiency, all while navigating a more complex supply environment. Companies that integrate clinician education, diversify supply chains, and deliver demonstrable value to health systems will be best positioned to influence purchasing decisions and sustain growth.

Moving forward, stakeholders should prioritize evidence generation, flexible manufacturing strategies, and customer-centric commercialization that addresses the needs of hospitals, ambulatory centers, home healthcare providers, and specialty clinics. By aligning product development with end-user workflows and regional logistics realities, organizations can reduce risk, accelerate adoption, and ensure that casting and splinting innovations translate into meaningful clinical and operational benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of 3D printing and scanning for patient specific cast fabrication in orthopedics
  • 5.2. Development of eco friendly biodegradable casting materials to reduce medical waste
  • 5.3. Incorporation of wearable sensor technology into orthopedic casts for real time monitoring
  • 5.4. Expansion of telehealth enabled remote cast adjustment and patient follow up services
  • 5.5. Use of antimicrobial and moisture resistant coatings in splints to prevent secondary infections
  • 5.6. Adoption of AI powered design software to optimize splint structures for improved patient comfort
  • 5.7. Growth of custom pediatric casting solutions addressing unique infant and toddler anatomical needs
  • 5.8. Rising demand for flexible thermoplastic splints in sports injury management and rapid mobilization

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Casting & Splinting Market, by Product Type

  • 8.1. Fiberglass Casts
  • 8.2. Plaster Casts
  • 8.3. Splints
    • 8.3.1. Dynamic Splints
    • 8.3.2. Static Splints
  • 8.4. Synthetic Casts
  • 8.5. Thermoplastic Casts

9. Casting & Splinting Market, by Material

  • 9.1. Fiberglass
  • 9.2. Plaster Of Paris
  • 9.3. Thermoplastics
    • 9.3.1. High Temperature Thermoplastics
    • 9.3.2. Low Temperature Thermoplastics

10. Casting & Splinting Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals
  • 10.4. Orthopedic Clinics

11. Casting & Splinting Market, by Application

  • 11.1. Corrective Casting
  • 11.2. Fractures
    • 11.2.1. Lower Limb Fractures
    • 11.2.2. Upper Limb Fractures
  • 11.3. Post Operative Immobilization

12. Casting & Splinting Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Casting & Splinting Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Casting & Splinting Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. 3M Company
    • 15.3.2. Johnson & Johnson
    • 15.3.3. BSN Medical GmbH
    • 15.3.4. Smith & Nephew plc
    • 15.3.5. Ossur hf.
    • 15.3.6. Zimmer Biomet Holdings, Inc.
    • 15.3.7. Medline Industries, LP
    • 15.3.8. Cardinal Health, Inc.
    • 15.3.9. McKesson Corporation
    • 15.3.10. Paul Hartmann AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CASTING & SPLINTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CASTING & SPLINTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CASTING & SPLINTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CASTING & SPLINTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CASTING & SPLINTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CASTING & SPLINTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CASTING & SPLINTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CASTING & SPLINTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CASTING & SPLINTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL CASTING & SPLINTING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL CASTING & SPLINTING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. ASEAN CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 323. ASEAN CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 324. ASEAN CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 325. GCC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. GCC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. GCC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. GCC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. GCC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 330. GCC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)

TABL